Загрузка...
SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir
December 2019 saw the emergence of a new epidemic of pneumonia of varying severity, called COVID-19, caused by a newly identified coronavirus, SARS-CoV-2. No therapeutic option is available to treat this infection that has already killed more than 235,000 people worldwide. This Viewpoint summarizes...
Сохранить в:
| Опубликовано в: : | Clin Infect Dis |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239253/ https://ncbi.nlm.nih.gov/pubmed/32409832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa587 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|